COL18A1 (1837-46) Antibody: sc-32720

COL18A1 Background Information
Collagen Type XV (COL15 gene product) and XVIII (COL18 gene product) form the new subgroup MULTIPLEXIN, within the diverse family of collagens, which contains nineteen distinct types of collagens found in vertebrates. Both Collagen Type XV and Collagen XVIII are characterized by extensive interruptions in their collagenous sequences. Members of the MULTIPLEXIN subgroup contain polypeptides with multiple triple-helical domains separated and flanked by non-triple-helical regions. Type XV is predominantly expressed in internal organs such as adrenal gland, kidney and pancreas. Type XVIII encodes two different a1 chains, which have different signal peptides and variant N-terminal non-collagenous NC1 domains of 495 and 303 amino acids. The long variant NC1-434 Type XVIII mRNAs are promi-nently expressed in liver, while the variant NC1-303 mRNAs are predominantly expressed in heart, kidney, placenta, prostate, ovary, skeletal muscle and small intestine. Endostatin is a fragment of the C-terminal domain NC1 of Collagen Type XV and Type XVIII that inhibits angiogenesis and tumor growth. Unlike endostatin-XVIII, endostatin-XV does not bind zinc or heparin, however both endostatins can inhibit chorioallantoic membrane angiogenesis induced by basic FGF or VEGF. Collagen Type XV and XVIII are also widely present in basement membrane zones, suggesting their roles in basement membrane-stromal interactions and involvement with angiogenic and pathological processes.